Funded Research

  • Novel Drug Targets for High Grade Serous Ovarian Cancer identified through Induced Pluripotent Stem Cell Modeling of Disease
    $500,000 Tower Senior Investigator Grant

    Faults in high risk genes cause high grade serous ovarian cancer (HGSOC). This cancer is often lethal in patients. Novel drugs are needed to improve treatment and patient outcomes. We plan to use cells from individuals carrying high risk genes to develop precision models of their disease and then cutting edge methods in genomics and functional screens to identify novel therapeutic targets that can be tested for their potential to treat patients with HGSOC. Ultimately we expected these studies will improve survival rates in patients that get HGSOC because they carry faulty genes.

    Simon Gayther, PhD
    Cedars-Sinai Medical Center

Impact begins here,
and it starts with you.

All of our research is made possible through the generous support of people like you.

Will you join us in the fight for a future free from the burden of cancer?

donate to research today

    I would like to learn more about:
    We respect your privacy, and will keep your personal information private and secure.